These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7474664)

  • 1. Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
    Arnadottir M; Thysell H; Dallongeville J; Fruchart JC; Nilsson-Ehle P
    Kidney Int; 1995 Sep; 48(3):779-84. PubMed ID: 7474664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired metabolism of high density lipoprotein in uremic patients.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.
    Goldberg A; Sherrard DJ; Brunzell JD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1173-82. PubMed ID: 400739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.
    Chan MK; Persaud J; Varghese Z; Moorhead JF
    Kidney Int; 1984 May; 25(5):812-8. PubMed ID: 6471667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitro.
    Arnadottir M; Dallongeville J; Fruchart JC; Nilsson-Ehle P
    Metabolism; 1996 Jun; 45(6):686-90. PubMed ID: 8637441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Metabolism; 1977 Feb; 26(2):179-86. PubMed ID: 834151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study.
    Garenc C; Pérusse L; Gagnon J; Chagnon YC; Bergeron J; Després JP; Province MA; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C
    Metabolism; 2000 Apr; 49(4):432-9. PubMed ID: 10778864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.
    Arnadóttir M
    Scand J Clin Lab Invest; 1997 Feb; 57(1):1-11. PubMed ID: 9127452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone is not an inhibitor of lipoprotein lipase activity.
    Arnadottir M; Nilsson-Ehle P
    Nephrol Dial Transplant; 1994; 9(11):1586-9. PubMed ID: 7870347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
    Ding Y; Wang Y; Zhu H; Fan J; Yu L; Liu G; Liu E
    Transgenic Res; 2011 Aug; 20(4):867-75. PubMed ID: 21120692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
    Kobayashi J; Takahashi K; Tashiro J; Shirai K; Saito Y; Yoshida S; Hashimoto H; Fukamachi I; Niihara K; Sasaki N
    Arzneimittelforschung; 1994 Feb; 44(2):145-8. PubMed ID: 8147947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
    Asayama K; Ito H; Nakahara C; Hasegawa A; Kato K
    Pediatr Res; 1984 Aug; 18(8):783-8. PubMed ID: 6382139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.
    Oscarsson J; Ottosson M; Johansson JO; Wiklund O; Mårin P; Björntorp P; Bengtsson BA
    Metabolism; 1996 Mar; 45(3):370-7. PubMed ID: 8606646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein abnormalities in chronic renal failure and dialysis patients.
    Monzani G; Bergesio F; Ciuti R; Rosati A; Frizzi V; Serruto A; Vitali D; Benucci A; Tosi PL; Bandini S; Salvadori M
    Blood Purif; 1996; 14(3):262-72. PubMed ID: 8738541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia.
    Antikainen M; Holmberg C; Olivecrona T; Bengtsson-Olivecrona G; Labeur C; Rosseneu M; Taskinen MR
    Eur J Clin Invest; 1993 Jun; 23(6):368-74. PubMed ID: 8344337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.